Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.
about
Nicotine promotes tumor growth and metastasis in mouse models of lung cancerEvaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imagingSex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokersPET Imaging of the Human Nicotinic Cholinergic Pathway in AtherosclerosisTranslational research in nicotine dependenceInside-out neuropharmacology of nicotinic drugsNicotinic receptors in non-human primates: Analysis of genetic and functional conservation with humans.PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityNicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors.Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humansNeuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity.beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.Functional brain imaging of nicotinic effects on higher cognitive processes.Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoningMenthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure.Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study.Effects of smoking cessation on pain in older adults.Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapiesSmoking cessation in pain patientsEffect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine MetabolismPositron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder.Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in ratsΑ4β2 and α7 nicotinic acetylcholine receptor binding predicts choice preference in two cost benefit decision-making tasks.Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice.Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptorsImpact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primatesTreatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkeyPositron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder
P2860
Q21142724-132C2397-ED39-4BA7-B0E2-209151F0481DQ21195727-7A18215E-9D4A-438C-AB19-1778E546D49CQ24606315-4C8473FF-00C0-4D12-AE12-8C732EBEC68EQ26800058-B526534F-6DD0-4E4B-A58E-03F9028DFC42Q26852485-0CDEC8D1-D7C1-48A0-B1CA-AA0C1367496FQ27010347-916D9C18-4FB9-4553-B09F-FF92BA87A82AQ30371523-1D418DA1-6368-49FD-93C0-2FA38E963104Q30403978-CC4D0FC2-4E13-4EA1-BBAE-38AC37F3018BQ30422045-7AA26917-2CA6-4400-BBDD-AEBD4737D0ACQ30560877-5249AEFE-FF39-422C-93FC-45A4EE08BA3BQ30597187-34693851-FC00-476B-8120-A82C40D0701EQ33503660-4D42577A-3BCE-4543-BC55-440DF0BEDED4Q33551855-9DF23CCA-B714-4F75-AD13-2072B11DDFA5Q33935792-C8897CE7-B288-4D9B-A308-B13BC699E6A0Q34439566-FE45CF49-64B6-4585-9C1A-90313CF8EC0DQ34517579-5132C64D-863E-4AA7-8F6B-3AEAB5610960Q35066591-25EB5089-4E93-4DC5-A6A8-C1EAAE8EAB4FQ35073748-23474238-BC4D-4131-82E9-300B46B7DD45Q35089413-97DC1486-649D-4E3F-8F98-A52C0CE456BBQ35231037-6D4B0ED5-A124-4DB2-B7E1-E73EFFBB9735Q35694111-3A82F20E-C667-479F-B6A9-F9E89BEE6324Q35839355-8F1B44DC-C8CE-4011-B3C7-A8A4F9836889Q36050801-BB2A5302-FB0A-4285-8E75-F9DA6DCBFE93Q36076416-3DCA7075-E06D-4F90-B68B-63D725A421E6Q36252716-D48F7057-A17B-4DD0-8CC2-328AC96461C5Q36283969-ECC91AB8-D6BA-450B-8348-A27F2D4666E6Q36303529-DDFD7090-7B47-4019-88C0-EB5D27E80B51Q36372867-FFE20FE8-9512-446F-8E85-C99B6917F9C7Q36387711-D4E493D5-A1FE-4C14-B89F-081892AE0BF2Q36428395-EBB84023-E97C-470F-B9EA-A1418CD894FCQ36532722-6AC3F93D-C31C-4390-8BBD-45DB348DAF29Q36569391-F22C7FFB-E930-4AE3-AC9D-2D6076FE9E91Q36652326-DD372A96-51FA-4952-B4AE-01A0CCCE54FEQ36779488-43B10282-EF9F-4B2F-9331-02FBDBC3684FQ36840066-2637B478-A647-4743-9593-48FB1B84FB20Q36927768-FC78DA84-E1B1-4672-AAB1-6642248C255AQ36947632-9D061EFB-21CC-43AB-A888-939A709CCBA1Q36959844-CAC87078-D56F-417F-8699-063C662FB0BFQ36994843-FB760417-52DD-490B-8E26-BB3661B8C578Q37049887-6F3EA49A-E43E-4DF7-AA7C-106E4F0AAF6B
P2860
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@en
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@nl
type
label
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@en
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@nl
prefLabel
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@en
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@nl
P2093
P2860
P1476
Greater nicotinic acetylcholin ...... PET study with 2-18F-FA-85380.
@en
P2093
Alane S Kimes
Alexey G Mukhin
Andrew G Horti
Carlo S Contoreggi
D Bruce Vaupel
Elliot A Stein
John A Matochik
Olga Pavlova
Svetlana I Chefer
P2860
P304
P356
10.2967/JNUMED.108.050716
P407
P577
2008-09-15T00:00:00Z